How do aesthetics clinics convert more consultations into treatments?

What actually happens between a consultation and a booked treatment?

Three things, in order: the patient has to trust the practitioner, understand what is being proposed and what it costs, and be given a way to say yes that does not require deciding on the spot. Clinics that struggle with conversion usually have a gap in one of those three, not a pricing problem. A patient who leaves confused about the plan, unsure what they will pay in total, or who felt rushed, will go away to "think about it" and often never comes back. A patient who arrives already informed, meets a practitioner who explains clearly, and is given a simple way to commit when ready has none of those reasons to drift away. This guide covers the regulatory framework that shapes what a compliant consultation can and cannot do, then the practical mechanics of qualification, the treatment plan, pricing presentation, and follow-up.

What do UK regulators actually require during a cosmetic consultation?

The requirements differ by who is doing the treatment, but the direction of travel across every UK regulator is the same: more time for the patient to decide, not less, and consent that cannot be handed off to non-clinical staff.

This is a summary for clinic owners, not legal or professional advice. Check current guidance with the relevant regulator before writing your own consultation protocol.

Does a cooling-off period hurt conversion?

Not in practice, and treating it as an obstacle is the wrong frame. GMC guidance does not fix a specific number of days: the amount of reflection time a patient needs depends on how invasive, complex, permanent and risky the intervention is, and how many options they are weighing up. For a simple, low-risk treatment that may be a short pause; the judgement belongs to the clinician. For a course of treatment, a filler plan across several sessions, or anything with more permanence, it reasonably means a second conversation before the first treatment.

The reframe that helps conversion: reflection time is not lost time, it is the gap in which a patient goes from "interested" to "decided," provided you give them something to decide with. A patient sent away with nothing but a business card thinks about price and doubt. A patient sent away with a written treatment plan, photos of what was discussed, and a clear next step thinks about the plan you gave them. The regulator's requirement and good practice point the same way: give the patient real material to decide with, then follow up on a schedule (see below).

How does qualifying a patient before the consultation change what happens in it?

A consultation booked with a patient who has already confirmed the treatment they want, that they are a plausible candidate for it, their rough budget, and when they want to start, is a different meeting to one booked with whoever filled in a form. The practitioner spends the appointment on the clinical assessment and the plan, not on discovering thirty seconds before the end that the patient's budget is a third of the proposed course, or that they were really asking about a different treatment.

Practically, that means checking four things before a slot is offered, not during the appointment (the same checks that decide whether a lead books at all):

1. Which treatment the patient is asking about, in their own words.
2. Whether anything in what they say flags them as a poor candidate for that treatment, so the clinic can direct them to the right first step (which might be a different treatment, or a GP referral, rather than a booking).
3. An honest sense of budget, so the practitioner is not presenting a plan the patient was never going to fund.
4. When they actually want to start, so the diary offers a slot they will keep rather than a placeholder three weeks out that quietly falls away.

Worked illustration, not a benchmark: a clinic running 40 unqualified consultation enquiries a month, where a fifth turn out to be a mismatch on treatment, budget or timing once they are in the room, is spending eight practitioner appointments a month on meetings that were never going to convert. At even 30 minutes of practitioner time per consultation, that is four hours a month, before counting the diary slot that could have gone to a patient who was ready to book. Filtering those eight out before the appointment does not create eight new bookings, but it does return four hours of practitioner time and, more importantly, replaces four low-probability slots with four the clinic can offer to a qualified patient instead.

How should the treatment plan and pricing be presented?

In writing, in full, before the patient leaves the room. Verbal pricing that the patient half-remembers by the time they get to the car park invites a follow-up call to "just check what we said," and every extra step between the consultation and the decision loses some patients. A treatment plan that converts well tends to have:

• The exact treatment or course being proposed, named the way the patient will recognise it, not just an internal product code.
• The total cost, not just the per-session price, if it is a course. A patient who is quoted "£250 a session" and only later discovers it is a course of four is far more likely to feel misled than one told "£1,000 across four sessions" up front.
• What is and is not included: reviews, touch-ups, aftercare products.
• A realistic timeline for results and for the full course.
• The deposit or payment structure and what happens to it if the patient reschedules or does not proceed (see what UK law says about deposits).

Financial transparency is also a regulatory point, not just good service. GMC guidance requires doctors to market their services responsibly, "without making unjustifiable claims about interventions, trivialising the risks involved, or using promotional tactics that might encourage people to make ill-considered decisions", and the GMC publishes a case study specifically on time-limited offers. Write the plan so a patient's family member, reading it later with no context, would understand exactly what was agreed and what it costs.

What happens when a patient does not decide at the consultation?

Most will not, and that is by design given the cooling-off expectations above, so the follow-up process matters as much as the consultation itself. An undecided patient who hears nothing again assumes the clinic was not that interested, or simply forgets amid everything else competing for their attention. A follow-up sequence that respects the reflection-time guidance (it is information and a way to say yes, not repeated pressure to decide faster) looks like this:

1. Same day or next morning: send the written treatment plan and pricing, if it was not already handed over in the room.
2. Around day 3 to 4: a short, genuinely useful check-in, for example answering a question they raised in the consultation, not a generic "just checking in."
3. Around day 10 to 14: a direct, low-pressure ask about whether they would like to go ahead and book, with the plan attached again so they do not have to search for it.
4. Around day 30: a final, polite close-out message if there has been no response, so the patient is not left in limbo and the clinic can move them out of the active follow-up list.

The cadence above is a starting structure, not a rule from any regulator: adjust the spacing to the treatment's own reflection-time expectations. What matters is that it happens on a schedule and is tracked, rather than depending on a staff member remembering to call back between other jobs.

How should a clinic track consultation-to-treatment rate?

By practitioner, by treatment, and by month, not as a single clinic-wide number that hides what is actually happening. A clinic-wide rate can look healthy while one practitioner is converting at half the rate of another, or while a particular treatment consistently loses patients at the pricing conversation. The minimum worth tracking:

Worked illustration, not a benchmark: if a clinic runs 25 consultations a month and converts 12 into booked treatment, that is a 48% consultation-to-treatment rate. If the same clinic later finds that one practitioner converts 15 of 20 (75%) and the other converts 3 of 15 (20%), the clinic-wide 48% figure was masking a training or script issue worth far more attention than another round of ad spend. There is no independently verified UK industry benchmark for consultation-to-treatment conversion in private aesthetics that we could confirm from a primary source, so treat any number you see quoted elsewhere as unverified and measure your own instead.

What can non-clinical staff do, and where is the line?

Reception and support staff can do almost everything around the consultation: booking the slot, sending the written treatment plan once the clinician has agreed it, chasing a deposit, and running the scheduled follow-up messages described above. What GMC guidance draws a hard line around is the consent conversation itself: "it is your responsibility to discuss it with the patient and seek their consent, you must not delegate this responsibility" applies to the doctor carrying out the intervention, and the same principle (a clinical decision belongs to the clinician, not to whoever is best at closing a sale) runs through the JCCP's Code of Practice for non-healthcare practitioners on its voluntary register. In practice this means a sales-incentivised member of staff should never be the one asking a patient to confirm they want to go ahead with a specific clinical intervention. They can absolutely make it easy to say yes once the clinician has had that conversation: a simple payment link, a clear next appointment slot, and a friendly follow-up. The distinction is who is asking the question, not how efficiently the administrative side runs.

Does compliant marketing before the consultation change how it converts?

Yes, because a consultation that starts from an honest expectation converts more easily than one that starts by correcting a misleading ad. If a patient arrives believing a price, a timeline or a guaranteed outcome that the ad implied but the clinic cannot actually deliver, the consultation's first job becomes damage control rather than assessment and planning, and that damaged trust is hard to recover inside one appointment. The Advertising Standards Authority's targeting rules for cosmetic interventions, in force since 25 May 2022, require that marketing for these treatments must not be directed at under-18s through media selection or context; treating that kind of platform-level compliance as a baseline, alongside not overstating results or downplaying risk in ad copy, keeps the expectation set at the consultation stage close to what the practitioner can actually deliver. When the ad, the landing page and the treatment plan say the same thing, there are fewer "that's not what I thought I was signing up for" moments in the room.

How does PatientFlow handle this?

PatientFlow's job stops at the consultation room door, deliberately. We run Meta ads from the clinic's own ad account, answer every enquiry on WhatsApp in under 60 seconds, and qualify treatment, suitability, budget and timing before a slot is offered. The patient pays a deposit through the checkout to confirm the consultation, and the booking lands in the clinic's diary and in the PatientFlow portal with the full WhatsApp transcript, so the practitioner walks in already knowing what the patient wants and what they said about budget and timing. Dr Motox, a UK clinic with three sites, took 160 deposit-paid consultation bookings in four months of 2026 at £36 a booking through this process. We guarantee 50 deposit-paid consultations in 90 days, or we keep working at no extra cost until they land, because that is what we control. What happens once the patient is in the room, the assessment, the plan, the consent conversation and the follow-up, is the clinic's, and the section above is what the evidence and the regulators say about doing that part well.

A consultation-to-treatment checklist

1. Qualify treatment, suitability, budget and timing before the consultation is booked.
2. Know which regulator's rules apply to whoever is seeing the patient (GMC, NMC, GDC or JCCP) and build the consent and reflection-time process around it.
3. Never let anyone other than the treating clinician take consent or apply pressure to decide.
4. Hand over a written treatment plan with total pricing before the patient leaves.
5. Run a scheduled follow-up sequence for undecided patients, spaced to the treatment's own reflection-time expectations.
6. Track consultation-to-treatment rate by practitioner and by treatment, monthly, not just as one clinic-wide figure.